RETRACTED ARTICLE: CD109 Mediates Cell Survival in Hepatocellular Carcinoma Cells

被引：0
|
作者：
Guijuan Zong
Zhiwei Xu
Shusen Zhang
Yifen Shen
Huiyuan Qiu
Guizhou Zhu
Song He
Tao Tao
Xudong Chen
机构：
[1] Affiliated Cancer Hospital of Nantong University,Department of Pathology
[2] Nantong University,Jiangsu Province Key Laboratory for Inflammation and Molecular Drug Target, Department of Immunology, Medical College
[3] Tohoku Pharmaceutical University,Division of Regulatory Glycobiology, Institute of Molecular Biomembrane and Glycobiology
[4] Affiliated Hospital of Nantong University,Department of Gastroenterology
来源：
Digestive Diseases and Sciences | 2016年 / 61卷
关键词：
CD109; HCC; Prognosis; Proliferation; Apoptosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2303 / 2314
页数：11
相关论文
共 50 条
  • [21] CD109 acts as a gatekeeper of the epithelial trait by suppressing epithelial to mesenchymal transition in squamous cell carcinoma cells in vitro
    Zhou, Shufeng
    da Silva, Sabrina Daniela
    Siegel, Peter M.
    Philip, Anie
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [22] CD109 acts as a gatekeeper of the epithelial trait by suppressing epithelial to mesenchymal transition in squamous cell carcinoma cells in vitro
    Shufeng Zhou
    Sabrina Daniela da Silva
    Peter M. Siegel
    Anie Philip
    Scientific Reports, 9
  • [23] Human Hepatic Progenitor Cells Express Hematopoietic Cell Markers CD45 and CD109
    Li, Jun
    Xin, Jiaojiao
    Zhang, Liyuan
    Wu, Jian
    Jiang, Longyan
    Zhou, Qian
    Li, Jun
    Guo, Jing
    Cao, Hongcui
    Li, Lanjuan
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2014, 11 (01): : 65 - 79
  • [24] Pathological analysis of Ki-67 and CD109 expression in tongue squamous cell carcinoma
    Hagiwara, Sumitaka
    Yamamoto, Noriyuki
    Furue, Hiroki
    Sakakura, Hiroki
    Shigetomi, Toshio
    Murakumo, Yoshiki
    Hibi, Hideharu
    Takahashi, Masahide
    Ueda, Minoru
    JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY MEDICINE AND PATHOLOGY, 2013, 25 (03) : 276 - 281
  • [25] CD109 is a component of exosome secreted from cultured cells
    Sakakura, Hiroki
    Mii, Shinji
    Hagiwara, Sumitaka
    Kato, Takuya
    Yamamoto, Noriyuki
    Hibi, Hideharu
    Takahashi, Masahide
    Murakumo, Yoshiki
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 469 (04) : 816 - 822
  • [26] Reduced expression of CD109 in tumor-associated endothelial cells promotes tumor progression by paracrine interleukin-8 in hepatocellular carcinoma
    Ye, Bo-Gen
    Sun, Hui-Chuan
    Zhu, Xiao-Dong
    Chai, Zong-Tao
    Zhang, Yuan-Yuan
    Ao, Jian-Yang
    Cai, Hao
    Ma, De-Ning
    Wang, Cheng-Hao
    Qin, Cheng-Dong
    Gao, Dong-Mei
    Tang, Zhao-You
    ONCOTARGET, 2016, 7 (20) : 29333 - 29345
  • [27] Serum CD109 levels reflect the node metastasis status in head and neck squamous cell carcinoma
    Hagiwara, Sumitaka
    Sasaki, Eiichi
    Hasegawa, Yasuhisa
    Suzuki, Hidenori
    Nishikawa, Daisuke
    Beppu, Shintaro
    Terada, Hoshino
    Sawabe, Michi
    Takahashi, Masahide
    Hanai, Nobuhiro
    CANCER MEDICINE, 2021, 10 (04): : 1335 - 1346
  • [28] CD109 expression promotes cell activity and enhances EGF signaling in human glioblastoma cells
    Murakumo, Yoshiki
    Zhang, Jing-Min
    Takahashi, Masahide
    CANCER RESEARCH, 2010, 70
  • [29] CD109 is identified as a potential nasopharyngeal carcinoma biomarker using aptamer selected by cell-SELEX
    Jia, Wenting
    Ren, Caiping
    Wang, Lei
    Zhu, Bin
    Jia, Wei
    Gao, Menghui
    Zeng, Fei
    Zeng, Liang
    Xia, Xiaomeng
    Zhang, Xiaobing
    Fu, Ting
    Li, Shasha
    Du, Can
    Jiang, Xingjun
    Chen, Yuxiang
    Tan, Weihong
    Zhao, Zilong
    Liu, Weidong
    ONCOTARGET, 2016, 7 (34) : 55328 - 55342
  • [30] CD109 is a novel marker for squamous cell/adenosquamous carcinomas of the gallbladder
    Fengyun Dong
    Chuanfeng Lu
    Xiaocui Chen
    Yuan Guo
    Ju Liu
    Diagnostic Pathology, 10
12345